PillRx only · Injection, Solution · Intravenous
Acyclovir
Acyclovir Sodium
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
38
Rx · 2026 Q1
2.1K
Units dispensed
-81%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Fresenius Kabi USA, LLC | unknown | 6 | SUPPLYING |
| Zydus Lifesciences Limited | unknown | 2 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | unknown | 2 | SUPPLYING |
| Slate Run Pharmaceuticals, LLC | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Feb 18, 2021RECALLRecall (Class I): Acyclovir Sodium Injection 500mg/10mL (50mg/mL) vial NDC 68382-048-01, For Intravenous Infusion Only MUST BE DILUTED PR…
Crystallization: customer complaints for crystallization in finished product. — Recalling firm: Zydus Pharmaceuticals (USA) Inc — USA Nationwide
- Feb 18, 2021RECALLRecall (Class I): Acyclovir Sodium Injection 1000mg/20mL (50mg/mL) vial NDC 68382-049-01, For Intravenous Infusion Only MUST BE DILUTED P…
Crystallization: customer complaints for crystallization in finished product. — Recalling firm: Zydus Pharmaceuticals (USA) Inc — USA Nationwide